ACADIA Pharmaceuticals Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ACAD Nasdaq 2834 http://www.acadia-pharm.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for ACADIA Pharmaceuticals Inc.

SHAREHOLDER ALERT: Stephens & Stephens LLP Investigating the Officers and Directors of ACADIA Pharmaceuticals Inc. (ACAD) - Jul 30th, 2020 7:37 pm
Acadia Pharmaceuticals (ACAD) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Jul 29th, 2020 4:33 pm
People with Dementia and Caregivers Share the Significant Burden of Visual Hallucinations and Paranoid Delusions, New Survey Highlights - Jul 29th, 2020 1:00 pm
ACADIA (ACAD) to Report Q2 Earnings: What's in the Cards? - Jul 28th, 2020 3:33 pm
ACADIA Pharmaceuticals to Announce Second Quarter 2020 Financial Results on August 5, 2020 - Jul 22nd, 2020 8:05 pm
Acadia Pharma Dives On Unexpected Flop In Depression Treatment - Jul 21st, 2020 8:24 pm
Acadia Plunges 12% As Depressive Study Misses Goals; Analyst Says Buy - Jul 21st, 2020 7:46 am
U.S. FDA accepts Acadia's application for dementia drug - Jul 20th, 2020 9:30 pm
ACADIA Pharmaceuticals Announces U.S. FDA Accepted for Filing the Supplemental New Drug Application for NUPLAZID® (pimavanserin) for the Treatment of Hallucinations and Delusions Associated with Dementia-Related Psychosis - Jul 20th, 2020 8:03 pm
ACADIA Pharmaceuticals Announces Top-line Results from the Phase 3 CLARITY Study Evaluating Pimavanserin for the Adjunctive Treatment of Major Depressive Disorder - Jul 20th, 2020 8:02 pm
Did Hedge Funds Make The Right Call On ACADIA Pharmaceuticals Inc. (ACAD) ? - Jul 13th, 2020 12:54 am
Shareholders Are Thrilled That The ACADIA Pharmaceuticals (NASDAQ:ACAD) Share Price Increased 113% - Jul 8th, 2020 10:51 am
Why Acadia Pharmaceuticals (ACAD) Stock is a Compelling Investment Case - Jul 7th, 2020 2:42 pm
Biotech Could Burst Higher, Says Signal - Jun 29th, 2020 7:50 pm
3 “Strong Buy” Healthcare Stocks That Should Remain Healthy - Jun 17th, 2020 11:36 pm
ACADIA Files sNDA for Nuplazid in Dementia-Related Psychosis - Jun 16th, 2020 2:47 pm
Acadia Files Nuplazid Label Expansion; Analyst Sees ‘Significant’ Potential - Jun 16th, 2020 10:00 am
ACADIA Pharmaceuticals Submits Supplemental New Drug Application to U.S. FDA for NUPLAZID® (pimavanserin) for the Treatment of Hallucinations and Delusions Associated with Dementia-Related Psychosis - Jun 15th, 2020 1:00 pm
Why Is Acadia (ACAD) Down 7.6% Since Last Earnings Report? - Jun 6th, 2020 3:31 pm